In the CT26 and WEHI-164 syngeneic models, high frequency of complete regression (CR) of tumor was observed in anti-CTLA4 and TU2218 combination group, showing 60% (6/10), and 80% (8/10) of CR, respectively (Fig. 7a–d). The gene discussed is CTLA4; the disease is neoplasm.